Cladribine tablets as a way to stop MS therapy
Treatments studied
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study tests whether cladribine tablets can help people with stable, long-standing RRMS safely stop their current disease-modifying therapy. It may be an option if your MS has been quiet for years and you want to consider a treatment break.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 45 years old or older.
- You have relapsing-remitting MS (RRMS) for at least 10 years.
- Your MS has been stable (no relapses or new lesions) for at least 5 years while on a disease-modifying therapy.
- Your disability level (EDSS score) is between 0 and 6.0.
- You do not have a progressive form of MS.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether cladribine (vs an inactive placebo pill) can slow disability worsening in people with a non-active, progressive form of multiple sclerosis. It may help by reducing the immune activity that can drive ongoing nerve damage, even without recent relapses.
This trial tests whether treating relapsing multiple sclerosis (RRMS) aggressively and early with a specific medication can slow disease progression. You may qualify if you were recently diagnosed, have had recent disease activity, and are willing to take a strong immunosuppressive drug with regular MRI monitoring.
This study looks at whether people with early relapsing multiple sclerosis can safely stop ocrelizumab. Researchers will compare health and MRI findings over time to see if stopping helps or increases relapse risk.
This study looks at whether the amount of MS treatment-related “burden” in the mouth and body affects how well people stick to their disease-modifying therapy. It may help doctors understand which patients are more likely to have trouble following treatment after switching or starting certain MS medicines.
This trial tests a new treatment called TRX319 for people with progressive multiple sclerosis (MS) that has been getting worse. The study wants to see if this treatment can help slow down disability progression.
This trial tests a new treatment using your own immune cells trained with vitamin D to calm MS. It is for people with progressive MS who are not on other MS drugs.
Hear when a new Multiple sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.